PLSENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
PULSE BIOSCIENCES, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$47.55+3.12 (+7.02%)
Close on Oct 19, 2026
- Market cap
- $3.29B
- P/E (TTM)
- –
- Dividend yield
- –
PULSE BIOSCIENCES, INC. revenue by segment
By business segment
By product or service
| Revenue | TTM Q4 23 | TTM Q3 23 | TTM Q2 23 | TTM Q1 23 | TTM Q4 22 | TTM Q3 22 | TTM Q2 22 | TTM Q4 21 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| Cycle Units Products [Member] | $0 | $7.00K | $7.00K | $63.00K | $140.00K | $278.00K | $362.00K | $229.00K | – | -100.0% |
| System Products [Member] | $0 | – | – | – | – | – | – | – | – | – |
| Systems Products [Member] | – | – | – | – | – | $1.28M | $1.77M | $1.19M | – | – |
| Product [Member] | – | – | – | – | – | $1.55M | $2.13M | $1.42M | – | – |
By region
| Revenue | TTM Q4 23 | TTM Q3 23 | TTM Q2 23 | TTM Q1 23 | TTM Q4 22 | TTM Q3 22 | TTM Q2 22 | TTM Q4 21 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| North America [Member] | $0 | – | – | – | – | $1.30M | $1.71M | $1.18M | – | – |
| Rest of World [Member] | $0 | $0 | $0 | $51.00K | $183.00K | – | – | – | – | -100.0% |
| Rest Of World [Member] | – | – | – | – | – | $250.00K | $419.00K | $236.00K | – | – |
From the segment and revenue-disaggregation notes of Pulse Biosciences's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.